Related references
Note: Only part of the references are listed.Phenotypic switch to eczema in patients receiving biologics for plaque psoriasis: a systematic review
A. Al-Janabi et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Mixed profile of cytokines in paradoxical eczematous eruptions associated with anti-IL-17 therapy
Pablo Chicharro et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Eczematous eruption during anti-interleukin 17 treatment of psoriasis: an emerging condition
M. Napolitano et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Analysis of anti-tumour necrosis factor-induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics
E. Stoffel et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Genome-wide Comparative Analysis of Atopic Dermatitis and Psoriasis Gives Insight into Opposing Genetic Mechanisms
Hansjoerg Baurecht et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2015)
Mutual Antagonism of T Cells Causing Psoriasis and Atopic Eczema
Stefanie Eyerich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Predictive Factors of Eczema-Like Eruptions among Patients without Cutaneous Psoriasis Receiving Infliximab: A Cohort Study of 92 Patients
Abdolrasool Esmailzadeh et al.
DERMATOLOGY (2009)
Share Paper
